Brianne M. Brown

Ms. Brianne M. Brown

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2025 in Ophthalmology
Verified
Journal Article
Closed access
DCDouglas Chigane
Douglas Chigane
DPDrishti Pandya
Drishti Pandya
MSMuskaan Singh
Muskaan Singh
BBBrianne M. Brown
Brianne M. Brown
MLMichelle Lin
Michelle Lin
Jesse BerryJesse Berry
Jesse Berry

12 November 2024 in Retina
Verified
Journal Article
Open access
SKSWATHI KALIKI
SWATHI KALIKI
VVVijitha S. Vempuluru
Vijitha S. Vempuluru
KBKomal Rajendra Bakal
Komal Rajendra Bakal
SDSamten Dorji
Samten Dorji
VTVishakha Tanna
Vishakha Tanna
HGHigh-Risk Retinoblastoma Collaborative Study Group
High-Risk Retinoblastoma Collaborative Study Group
Purpose: To evaluate high-risk histopathological features following primary enucleation of eyes with retinoblastoma and assess the patient outcomes across continents. Methods: A retrospective study of 1,426 primarily enucleated retinoblastoma eyes from five continents. Results: Of all, 923 (65%) were from Asia (AS), 27 (2%) from Australia (AUS), 120 (8%) from Europe (EUR), 162 (11%) from North America (NA), and 194 (14%) from South America (SA). Based on the continent (AS vs. AUS vs. EUR vs. NA vs. SA), the histopathological features included massive choroidal invasion (31% vs. 7% vs. 13% vs. 19% vs. 27%, P = 0.001), postlaminar optic nerve invasion (27% vs. 0% vs. 16% vs. 21% vs. 19%, P = 0.0006), scleral infiltration (5% vs. 0% vs. 4% vs. 2% vs. 7%, P = 0.13), and microscopic extrascleral infiltration (4% vs. 0% vs. <1% vs. <1% vs. 4%, P = 0.68). Adjuvant chemotherapy with/without orbital radiotherapy was given to 761 (53%) patients. Based on Kaplan–Meier estimates in different continents (AS vs. AUS vs. EUR vs. NA vs. SA), the 6-year risk of orbital tumor recurrence was 5% versus 2% versus 0% versus 0% versus 12% (P < 0.001), systemic metastasis was reported in 8% versus 5% versus 2% versus 0% versus 13% (P = 0.001), and death in 10% versus 3% versus 2% versus 0% versus 11% (P < 0.001) patients. Conclusion: There is a wide variation in the infiltrative histopathological features of retinoblastoma across continents, resulting in variable outcomes. SA and AS had a higher risk of orbital tumor recurrence, systemic metastasis, and death compared to AUS, EUR, and NA.

26 January 2017 in Contemporary Clinical Trials
Verified
Journal Article
Closed access
PDF file
MHMichele Heisler
Michele Heisler
RMRebecca Mase
Rebecca Mase
BBBrianne M. Brown
Brianne M. Brown
SWShayla Wilson
Shayla Wilson
PRPamela J. Reeves
Pamela J. Reeves

1 August 2025 in JCO Precision Oncology
Verified
Journal Article
Open access
EHElaine Huang
Elaine Huang
SSShreya Sirivolu
Shreya Sirivolu
VYVenkata Yellapantula
Venkata Yellapantula
PKPrachi Kale
Prachi Kale
Peter KuhnPeter Kuhn
Peter Kuhn
Liya XuLiya Xu
Liya Xu

24 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
JRJasmeen Randhawa
Jasmeen Randhawa
Mary KimMary Kim
Mary Kim
APAshley Polski
Ashley Polski
MRMark William Reid
Mark William Reid
KMKristen Mascarenhas
Kristen Mascarenhas
Jesse BerryJesse Berry
Jesse Berry
The protective effects of breastfeeding on various childhood malignancies have been established but an association has not yet been determined for retinoblastoma (RB). We aimed to further investigate the role of breastfeeding in the severity of nonhereditary RB development, assessing relationship to (1) age at diagnosis, (2) ocular prognosis, measured by International Intraocular RB Classification (IIRC) or Intraocular Classification of RB (ICRB) group and success of eye salvage, and (3) extraocular involvement. Analyses were performed on a global dataset subgroup of 344 RB patients whose legal guardian(s) consented to answer a neonatal questionnaire. Patients with undetermined or mixed feeding history, family history of RB, or sporadic bilateral RB were excluded. There was no statistically significant difference between breastfed and formula-fed groups in (1) age at diagnosis (p = 0.20), (2) ocular prognosis measures of IIRC/ICRB group (p = 0.62) and success of eye salvage (p = 0.16), or (3) extraocular involvement shown by International Retinoblastoma Staging System (IRSS) at presentation (p = 0.74), lymph node involvement (p = 0.20), and distant metastases (p = 0.37). This study suggests that breastfeeding neither impacts the sporadic development nor is associated with a decrease in the severity of nonhereditary RB as measured by age at diagnosis, stage of disease, ocular prognosis, and extraocular spread. A further exploration into the impact of diet on children who develop RB is warranted.

3 June 2025
Verified
Journal Article
Open access
PDF file
DCDouglas Chigane
Douglas Chigane
DPDrishti Pandya
Drishti Pandya
BBBrianne M. Brown
Brianne M. Brown
MLMichelle Lin
Michelle Lin
ATAlexander Tseng
Alexander Tseng
Jesse BerryJesse Berry
Jesse Berry
Objective: Patients with retinoblastoma (RB) require serial examinations under anesthesia (EUA) to assess for response to treatment and disease recurrence. Monitoring for disease recurrence is complicated in patients with loss of fundoscopic view, such as with vitreous hemorrhage (VH) or cataract. Herein, we report a case of a 13-month-old male diagnosed with sporadic bilateral retinoblastoma, wherein the aqueous humor liquid biopsy was used to detect an occult tumor recurrence after 3.5 years of disease stability. Methodology: Case report. Results: A 13-month-old male diagnosed with sporadic bilateral retinoblastoma, International Intraocular Retinoblastoma Classification (IIRC) Group D1 in the right eye and Group E in the left eye, was initially treated with intravenous chemotherapy, intravitreal chemotherapy, and local consolidation. After 3.5 years of disease stability, the patient developed a massive vitreous hemorrhage in the left eye, which precluded a view of the posterior segment. EUA, B-scan ultrasonography, and magnetic resonance imaging (MRI) of the brain and bilateral orbits were inconclusive for recurrence. Aqueous humor liquid biopsy, LBSeq4Kids, is an analytically validated College of American Pathologists /Clinical Laboratory Improvement Amendments (CAP/CLIA) laboratory test available for clinical use at Children’s Hospital Los Angeles. Low pass whole-genome sequencing of aqueous humor cell-free DNA (cfDNA) demonstrated the presence of circulating tumor DNA consistent with an active intraocular recurrence. Enucleation of the left eye was performed and the histopathology confirmed active RB recurrence with massive choroidal invasion. Conclusions: Aqueous humor liquid biopsy can be used to guide clinical decision-making in RB, especially when there is a loss of fundus view and intraocular recurrence is suspected.